NCT01920256View on ClinicalTrials.gov

Provider-Initiated Regular Remote Interventions for Optimal Type 2 Diabetes Care

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2017

Conditions
Type 2 Diabetes
Interventions
OTHER

Remote, personalized type 2 diabetes care.

Diabetes and comorbidities will be managed with 1 clinic visit per year and frequent adjustments made remotely.

OTHER

Usual Endocrine care.

Diabetes and comorbidities management will provided by an endocrinologist

Trial Locations (1)

48109

University of Michigan Health System, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT01920256 - Provider-Initiated Regular Remote Interventions for Optimal Type 2 Diabetes Care | Biotech Hunter | Biotech Hunter